OCUMENSION THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.78 HKD | -1.02% |
|
-2.45% | +1.50% |
| 04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
| 04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 609M | - | |||||
| 723B | ||||||
| 595B | ||||||
| 369B | ||||||
| 332B | ||||||
| 282B |
